Name: Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: MD5192
Price: 4950 USD
Availability: InStock

1 INTRODUCTION 33 1.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION 33 1.3 MARKET SCOPE 34 1.3.1 STUDY INCLUSIONS AND EXCLUSIONS 34 1.3.2 MARKETS COVERED 35 1.3.3 YEARS CONSIDERED FOR STUDY 36 1.4 CURRENCY CONSIDERED 36 1.5 STAKEHOLDERS 37 1.6 SUMMARY OF CHANGES 37 2 RESEARCH METHODOLOGY 39 2.1 RESEARCH DATA 39 2.1.1 SECONDARY DATA 39 2.1.1.1 Key data from secondary sources 41 2.1.2 PRIMARY DATA 41 2.1.2.1 Key data from primary sources 43 2.1.2.2 Key industry insights 43 2.2 MARKET SIZE ESTIMATION 45 2.3 DATA TRIANGULATION 49 2.4 MARKET SHARE ESTIMATION 49 2.5 ASSUMPTIONS FOR STUDY 50 2.6 RESEARCH LIMITATIONS 50 2.6.1 SCOPE-RELATED LIMITATIONS 50 2.6.2 METHODOLOGY-RELATED LIMITATIONS 50 2.7 RISK ASSESSMENT 51 3 EXECUTIVE SUMMARY 52 4 PREMIUM INSIGHTS 56 4.1 INSULIN DELIVERY DEVICES: MARKET OVERVIEW 56 4.2 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE AND COUNTRY 57 4.3 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHICAL MIX 58 4.4 INSULIN DELIVERY DEVICES MARKET: REGIONAL MIX 58 4.5 INSULIN DELIVERY DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS 59 5 MARKET OVERVIEW 60 5.1 INTRODUCTION 60 5.2 MARKET DYNAMICS 60 5.2.1 DRIVERS 61 5.2.1.1 Growth in prevalence of diabetic population 61 5.2.1.2 Technological advancements in insulin delivery devices 62 5.2.1.3 Government support and favorable reimbursement schemes to favor the market growth 64 5.2.2 RESTRAINTS 64 5.2.2.1 High cost and lack of reimbursement in emerging economies 64 5.2.2.2 Needle anxiety in patients to affect growth of pen needles and syringes market 65 5.2.2.3 Oral insulin as alternative drug delivery method 65 5.2.3 OPPORTUNITIES 66 5.2.3.1 Increase in research & development activities and strategic partnerships 66 5.2.3.2 Increase in healthcare expenditure on diabetes care 67 5.2.3.3 Advances in insulin syringe and needle technology 67 5.2.3.4 Mandates pertaining to safety-engineered medical needles 68 5.2.4 CHALLENGES 68 5.2.4.1 Needlestick injuries and misuse of injection pens 68 5.2.4.2 Lack of interoperability among insulin delivery devices 69 5.3 REGULATORY ANALYSIS 70 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 5.3.2 REGULATORY FRAMEWORK 72 5.3.2.1 North America 72 5.3.2.1.1 US 72 5.3.2.1.2 Canada 73 5.3.2.2 Europe 74 5.3.2.3 Asia Pacific 76 5.3.2.3.1 Japan 76 5.3.2.3.2 China 76 5.3.2.3.3 India 77 5.3.2.3.4 Australia 77 5.3.2.4 Latin America 78 5.3.2.4.1 Brazil 79 5.3.2.4.2 Mexico 79 5.3.2.5 Middle East 79 5.3.2.6 Africa 79 5.4 INDUSTRY TRENDS 80 5.4.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 80 5.4.2 SYNCHRONIZATION OF SMART INSULIN PENS WITH CONTINUOUS GLUCOSE MONITORING SYSTEMS PROMOTES DIABETES DATA SHARING 81 5.4.3 INCREASE IN NUMBER OF COLLABORATIONS AMONG STAKEHOLDERS 82 5.5 REIMBURSEMENT SCENARIO 82 5.5.1 GLOBAL COVERAGE AND REIMBURSEMENT 82 5.6 TECHNOLOGY ANALYSIS 84 5.7 TECHNOLOGY ANALYSIS 85 5.7.1 KEY TECHNOLOGIES 85 5.7.1.1 Automated insulin delivery 85 5.7.2 COMPLEMENTARY TECHNOLOGIES 85 5.7.2.1 Bluetooth 85 5.7.3 ADJACENT TECHNOLOGIES 86 5.7.3.1 Continuous glucose monitoring 86 5.8 KEY CONFERENCES & EVENTS 86 5.9 PRICING ANALYSIS 87 5.9.1 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY KEY PLAYER 88 5.9.2 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY REGION 88 5.10 TRADE ANALYSIS 89 5.11 PATENT ANALYSIS 90 5.11.1 PATENT PUBLICATION TRENDS FOR INSULIN DELIVERY DEVICES 90 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN INSULIN DELIVERY DEVICES MARKET 90 5.12 SUPPLY CHAIN ANALYSIS 93 5.13 VALUE CHAIN ANALYSIS 94 5.14 ECOSYSTEM MARKET MAP 95 5.15 CASE STUDY ANALYSIS 96 5.15.1 OMNIPOD 5 FACILITATED EFFECTIVE INSULIN MANAGEMENT FOR YOUNG ATHLETES, SUPPORTING CONTINUITY IN TRAINING AND COMPETITION 96 5.15.2 MEDTRONIC MINIMED INSULIN PUMP ENHANCED GLUCOSE CONTROL, IMPROVING DAILY MANAGEMENT FOR PEOPLE WITH DIABETES 97 5.15.3 SMART INSULIN DELIVERY WITH MEDTRONIC INPEN FOR IMPROVED DIABETES MANAGEMENT 98 5.16 PORTER’S FIVE FORCES ANALYSIS 98 5.16.1 INTENSITY OF COMPETITIVE RIVALRY 99 5.16.2 BARGAINING POWER OF SUPPLIERS 99 5.16.3 BARGAINING POWER OF BUYERS 99 5.16.4 THREAT OF SUBSTITUTES 100 5.16.5 THREAT OF NEW ENTRANTS 100 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA 100 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 100 5.17.2 BUYING CRITERIA 101 5.18 ADJACENT MARKET ANALYSIS 102 5.19 INVESTMENT & FUNDING SCENARIO 102 5.20 UNMET NEEDS/END-USER EXPECTATIONS IN INSULIN DELIVERY DEVICES MARKET 102 5.21 TRENDS/DISRUPTION IMPACTING CUSTOMER’S BUSINESS 104 5.22 IMPACT OF AI/GENERATIVE AI ON INSULIN DELIVERY DEVICES MARKET 104 6 INSULIN DELIVERY DEVICES MARKET, BY TYPE 106 6.1 INTRODUCTION 107 6.2 INSULIN PENS 108 6.2.1 ADVANCED AND CONVENIENT SOLUTIONS FOR INSULIN ADMINISTRATION TO DRIVE MARKET 108 6.2.2 REUSABLE INSULIN PENS 109 6.2.2.1 Technology innovations offering cost-effectiveness to boost growth 109 6.2.3 DISPOSABLE INSULIN PENS 111 6.2.3.1 Ease of use to drive market, though shift toward eco-friendly environment can challenge growth 111 6.3 INSULIN PUMPS 113 6.3.1 PRECISION OFFERED BY NEWER AND MORE REFINED TECHNOLOGY TO DRIVE INSULIN PUMPS MARKET 113 6.3.2 TETHERED INSULIN PUMPS 115 6.3.2.1 Increase in collaborations and partnerships between companies to develop integrated CGM systems to drive market 115 6.3.3 TUBELESS INSULIN PUMPS 116 6.3.3.1 Use of artificial intelligence and technological advancements to boost market 116 6.4 INSULIN PEN NEEDLES 118 6.4.1 STANDARD INSULIN PEN NEEDLES 119 6.4.1.1 Affordability of standard insulin pen needles over safety pen needles to propel growth 119 6.4.2 SAFETY INSULIN PEN NEEDLES 123 6.4.2.1 Reduced chances of infection and accidental pricking to drive market 123 6.5 INSULIN SYRINGES 125 6.5.1 COMMONLY USED DELIVERY MEANS CHALLENGED BY SAFETY CONCERNS AND AWARENESS OF AFFORDABLE ALTERNATIVES 125 6.6 OTHER INSULIN DELIVERY DEVICES 127 7 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE 130 7.1 INTRODUCTION 131 7.2 TYPE 1 DIABETES 131 7.2.1 CHRONIC NATURE OF TYPE 1 DIABETES, COMBINED WITH SIGNIFICANT INCIDENCE IN CHILDREN AND YOUNG ADULTS, TO DRIVE GROWTH 131 7.3 TYPE 2 DIABETES 134 7.3.1 RISING PREVALENCE OF TYPE 2 DIABETES, DRIVEN BY LIFESTYLE-RELATED RISK FACTORS AND EARLIER DISEASE ONSET TO FUEL MARKET 134 8 INSULIN DELIVERY DEVICES MARKET, BY END USER 137 8.1 INTRODUCTION 138 8.2 HOME CARE SETTINGS 139 8.2.1 INCREASE IN AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES TO FUEL SELF/HOME HEALTHCARE 139 8.3 HOSPITALS & CLINICS 141 8.3.1 RISE IN DEMAND FOR POINT-OF-CARE TESTING IN HOSPITALS TO BOOST MARKET GROWTH 141 8.4 OTHER END USERS 144 9 INSULIN DELIVERY DEVICES MARKET, BY REGION 146 9.1 INTRODUCTION 147 9.2 NORTH AMERICA 148 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 149 9.2.2 US 154 9.2.2.1 Largest share of North American insulin delivery device market 154 9.2.3 CANADA 159 9.2.3.1 Rise in government support to boost market in Canada 159 9.3 EUROPE 165 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 165 9.3.2 GERMANY 170 9.3.2.1 Germany to dominate European insulin delivery devices market 170 9.3.3 UK 175 9.3.3.1 Government support and research funding to drive market growth in UK 175 9.3.4 FRANCE 179 9.3.4.1 High insurance coverage and increasing affordability to fuel market 179 9.3.5 ITALY 183 9.3.5.1 Increase in government spending to drive insulin delivery device growth in Italy 183 9.3.6 SPAIN 188 9.3.6.1 Minimal co-payments and full reimbursement to drive market growth in Spain 188 9.3.7 REST OF EUROPE (ROE) 192 9.4 ASIA PACIFIC 196 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 196 9.4.2 CHINA 203 9.4.2.1 China to dominate Asia Pacific’s insulin delivery devices market 203 9.4.3 JAPAN 207 9.4.3.1 Rise in aging population and high diabetes cases to drive growth in Japan 207 9.4.4 INDIA 212 9.4.4.1 Rise in diabetes cases and affordable local manufacturing to fuel insulin device demand in India 212 9.4.5 AUSTRALIA 216 9.4.5.1 Government subsidies to support market growth 216 9.4.6 SOUTH KOREA 221 9.4.6.1 Rise in diabetes cases and strong government healthcare support to boost market 221 9.4.7 REST OF ASIA PACIFIC 225 9.5 LATIN AMERICA 229 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 229 9.5.2 BRAZIL 234 9.5.2.1 Brazil to account for largest share in Latin American insulin delivery devices market 234 9.5.3 MEXICO 239 9.5.3.1 Growth in regulatory support to propel market 239 9.5.4 REST OF LATIN AMERICA 243 9.6 MIDDLE EAST & AFRICA 247 9.6.1 MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA 247 9.6.2 GCC COUNTRIES 252 9.6.2.1 Rise in diabetes prevalence and high per capita healthcare expenditure to drive market in GCC countries 252 9.6.3 REST OF THE MIDDLE EAST & AFRICA 257 10 COMPETITIVE LANDSCAPE 262 10.1 INTRODUCTION 262 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 262 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN INSULIN DELIVERY DEVICES MARKET 262 10.3 REVENUE ANALYSIS, 2022–2024 264 10.4 MARKET SHARE ANALYSIS, 2024 264 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 266 10.5.1 STARS 267 10.5.2 EMERGING LEADERS 267 10.5.3 PERVASIVE PLAYERS 267 10.5.4 PARTICIPANTS 267 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 269 10.5.5.1 Company footprint 269 10.5.5.2 Type footprint 270 10.5.5.3 Region footprint 271 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 272 10.6.1 PROGRESSIVE COMPANIES 272 10.6.2 RESPONSIVE COMPANIES 272 10.6.3 DYNAMIC COMPANIES 272 10.6.4 STARTING BLOCKS 272 10.6.5 COMPETITIVE BENCHMARKING 274 10.6.5.1 DETAILED LIST OF KEY STARTUPS/SMES, 2024 274 10.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 275 10.7 BRAND/PRODUCT COMPARISON 276 10.8 COMPANY VALUATION & FINANCIAL METRICS 277 10.8.1 FINANCIAL METRICS 277 10.8.2 COMPANY VALUATION 277 10.9 R&D ASSESSMENT OF KEY PLAYERS 278 10.10 COMPETITIVE SCENARIO 278 10.10.1 PRODUCT LAUNCHES & APPROVALS 278 10.10.2 DEALS 285 10.10.3 EXPANSIONS 291 10.10.4 OTHER DEVELOPMENTS 294 11 COMPANY PROFILES 296 11.1 KEY PLAYERS 296 11.1.1 EMBECTA CORP. (FORMERLY BECTON, DICKINSON AND COMPANY DIABETES CARE BUSINESS) 296 11.1.1.1 Business overview 296 11.1.1.2 Products offered 297 11.1.1.3 Recent developments 298 11.1.1.3.1 Product launches and approvals 298 11.1.1.3.2 Deals 298 11.1.1.3.3 Expansions 299 11.1.1.3.4 Other developments 299 11.1.1.4 MnM view 299 11.1.1.4.1 Right to win 299 11.1.1.4.2 Strategic choices 300 11.1.1.4.3 Weaknesses & competitive threats 300 11.1.2 NOVO NORDISK A/S 301 11.1.2.1 Business overview 301 11.1.2.2 Products offered 302 11.1.2.3 Recent developments 303 11.1.2.3.1 Product launches and approvals 303 11.1.2.3.2 Deals 303 11.1.2.3.3 Other developments 305 11.1.2.4 MnM view 306 11.1.2.4.1 Right to win 306 11.1.2.4.2 Strategic choices 306 11.1.2.4.3 Weaknesses & competitive threats 306 11.1.3 MEDTRONIC 307 11.1.3.1 Business overview 307 11.1.3.2 Products offered 308 11.1.3.3 Recent developments 309 11.1.3.3.1 Product launches and approvals 309 11.1.3.3.2 Deals 310 11.1.3.3.3 Expansions 311 11.1.3.3.4 Other developments 311 11.1.3.4 MnM view 311 11.1.3.4.1 Right to win 311 11.1.3.4.2 Strategic choices 312 11.1.3.4.3 Weaknesses & competitive threats 312 11.1.4 SANOFI 313 11.1.4.1 Business overview 313 11.1.4.2 Products offered 314 11.1.4.3 Recent developments 315 11.1.4.3.1 Product launches and approvals 315 11.1.4.3.2 Expansions 315 11.1.4.3.3 Other developments 316 11.1.4.4 MnM view 316 11.1.4.4.1 Right to win 316 11.1.4.4.2 Strategic choices 316 11.1.4.4.3 Weaknesses & competitive threats 317 11.1.5 ELI LILLY AND COMPANY 318 11.1.5.1 Business overview 318 11.1.5.2 Products offered 319 11.1.5.3 Recent developments 320 11.1.5.3.1 Product launches and approvals 320 11.1.5.3.2 Deals 320 11.1.5.3.3 Expansions 321 11.1.5.3.4 Other developments 321 11.1.5.4 MnM view 322 11.1.5.4.1 Right to win 322 11.1.5.4.2 Strategic choices 322 11.1.5.4.3 Weaknesses and competitive threats 322 11.1.6 TANDEM DIABETES CARE, INC. 323 11.1.6.1 Business overview 323 11.1.6.2 Products offered 324 11.1.6.3 Recent developments 325 11.1.6.3.1 Product launches and approvals 325 11.1.6.3.2 Deals 326 11.1.7 INSULET CORPORATION 328 11.1.7.1 Business overview 328 11.1.7.2 Products offered 329 11.1.7.3 Recent developments 330 11.1.7.3.1 Product launches and approvals 330 11.1.7.3.2 Deals 332 11.1.7.3.3 Expansions 332 11.1.7.3.4 Other developments 333 11.1.8 BIOCON 334 11.1.8.1 Business overview 334 11.1.8.2 Products offered 335 11.1.8.3 Recent developments 336 11.1.8.3.1 Deals 336 11.1.8.3.2 Other developments 337 11.1.9 ROCHE DIABETES CARE 338 11.1.9.1 Business overview 338 11.1.9.2 Products offered 339 11.1.9.3 Recent developments 340 11.1.9.3.1 Product launches and approvals 340 11.1.10 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP) 341 11.1.10.1 Business overview 341 11.1.10.2 Products offered 342 11.1.10.3 Recent developments 342 11.1.10.3.1 Deals 342 11.1.11 YPSOMED 343 11.1.11.1 Business overview 343 11.1.11.2 Products offered 344 11.1.11.3 Recent developments 345 11.1.11.3.1 Product launches and approvals 345 11.1.11.3.2 Deals 346 11.1.11.3.3 Expansions 347 11.1.11.3.4 Other developments 348 11.1.12 MEDTRUM TECHNOLOGIES INC. 349 11.1.12.1 Business overview 349 11.1.12.2 Products offered 349 11.1.13 TERUMO CORPORATION 350 11.1.13.1 Business overview 350 11.1.13.2 Products offered 351 11.1.13.3 Recent developments 352 11.1.13.3.1 Product launches and approvals 352 11.1.13.3.2 Deals 352 11.1.13.3.3 Expansions 353 11.1.13.3.4 Other developments 353 11.1.14 WOCKHARDT LIMITED 354 11.1.14.1 Business overview 354 11.1.14.2 Products offered 355 11.1.14.3 Recent developments 355 11.1.14.3.1 Product launches and approvals 355 11.1.14.3.2 Other developments 356 11.1.15 NIPRO 357 11.1.15.1 Business overview 357 11.1.15.2 Products offered 358 11.1.15.3 Recent developments 359 11.1.15.3.1 Expansions 359 11.2 OTHER PLAYERS 360 11.2.1 CEQUR CORPORATION 360 11.2.2 EOFLOW CO., LTD. 361 11.2.3 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD 362 11.2.4 SOOIL DEVELOPMENTS CO., LTD 363 11.2.5 SUNGSHIM MEDICAL CO., LTD. 364 11.2.6 B.BRAUN SE 365 11.2.7 DEBIOTECH SA 366 11.2.8 JIANGSU DELFU MEDICAL DEVICE CO., LTD 367 11.2.9 HASELMEIER (A SUBSIDIARY OF MEDMIX) 368 11.2.10 MANNKIND CORPORATION 369 12 APPENDIX 370 12.1 DISCUSSION GUIDE 370 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 375 12.3 CUSTOMIZATION OPTIONS 377 12.4 RELATED REPORTS 377 12.5 AUTHOR DETAILS 378

TABLE 1 INCLUSION AND EXCLUSIONS 34 TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD) 36 TABLE 3 RISK ASSESSMENT: INSULIN DELIVERY DEVICES MARKET 51 TABLE 4 TOP 10 COUNTRIES/TERRITORIES WITH HIGHEST NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES, 2024 AND 2050 (MILLION) 62 TABLE 5 TOTAL DIABETES-RELATED HEALTH EXPENDITURE ACROSS REGIONS, 2024 AND 2050 (USD MILLION) 67 TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 72 TABLE 12 EUROPE: MEDICAL DEVICES, BY CLASS 74 TABLE 13 EUROPE: CONFORMITY ASSESSMENT 75 TABLE 14 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY 76 TABLE 15 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 76 TABLE 16 INDIA: MEDICAL DEVICE CLASSIFICATION 77 TABLE 17 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO 80 TABLE 18 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY 81 TABLE 19 RECENT COLLABORATIONS IN INSULIN DELIVERY DEVICE MARKET 82 TABLE 20 US: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT 82 TABLE 21 CANADA: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT 83 TABLE 22 UK: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT 83 TABLE 23 AUSTRALIA: INSULIN DELIVERY DEVICES COVERAGE AND REIMBURSEMENT 84 TABLE 24 OTHER COUNTRIES: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT 84 TABLE 25 INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 86 TABLE 26 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY KEY PLAYER, 2022–2024 (USD) 88 TABLE 27 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY REGION, 2022–2024 (USD) 88 TABLE 28 IMPORT DATA FOR INSULIN DELIVERY SYSTEMS (HS CODE: 901839), BY COUNTRY, 2020–2023 (USD THOUSAND) 89 TABLE 29 EXPORT DATA FOR INSULIN DELIVERY SYSTEMS (HS CODE: 901839), BY COUNTRY, 2020–2023 (USD THOUSAND) 89 TABLE 30 LIST OF PATENTS IN INSULIN DELIVERY DEVICES MARKET, 2022−2024 92 TABLE 31 INSULIN DELIVERY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 99 TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS 101 TABLE 33 KEY BUYING CRITERIA FOR END USERS 101 TABLE 34 UNMET NEEDS: INSULIN DELIVERY DEVICES MARKET 102 TABLE 35 END-USER EXPECTATIONS: INSULIN DELIVERY DEVICES MARKET 103 TABLE 36 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 107 TABLE 37 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 107 TABLE 38 INSULIN PENS MARKET, BY TYPE, 2022–2024 (USD MILLION) 108 TABLE 39 INSULIN PENS MARKET, BY TYPE, 2025–2030 (USD MILLION) 108 TABLE 40 REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 110 TABLE 41 REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 111 TABLE 42 DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 112 TABLE 43 DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 113 TABLE 44 INSULIN PUMPS MARKET, BY TYPE, 2022–2024 (USD MILLION) 114 TABLE 45 INSULIN PUMPS MARKET, BY TYPE, 2025–2030 (USD MILLION) 114 TABLE 46 TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 115 TABLE 47 TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 116 TABLE 48 TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 117 TABLE 49 TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 118 TABLE 50 INSULIN PEN NEEDLES MARKET, BY TYPE, 2022–2024 (USD MILLION) 119 TABLE 51 INSULIN PEN NEEDLES MARKET, BY TYPE, 2025–2030 (USD MILLION) 119 TABLE 52 STANDARD INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS 120 TABLE 53 STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 121 TABLE 54 STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 122 TABLE 55 SAFETY INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS 123 TABLE 56 SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 124 TABLE 57 SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 125 TABLE 58 INSULIN SYRINGES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 126 TABLE 59 INSULIN SYRINGES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 127 TABLE 60 OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 128 TABLE 61 OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 129 TABLE 62 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 131 TABLE 63 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 131 TABLE 64 INSULIN DELIVERY DEVICES MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2022–2024 (USD MILLION) 132 TABLE 65 INSULIN DELIVERY DEVICES MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2025–2030 (USD MILLION) 133 TABLE 66 INSULIN DELIVERY DEVICES MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2022–2024 (USD MILLION) 135 TABLE 67 INSULIN DELIVERY DEVICES MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2025–2030 (USD MILLION) 136 TABLE 68 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 138 TABLE 69 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 138 TABLE 70 INSULIN DELIVERY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2024 (USD MILLION) 140 TABLE 71 INSULIN DELIVERY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2025–2030 (USD MILLION) 141 TABLE 72 INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2024 (USD MILLION) 142 TABLE 73 INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2025–2030 (USD MILLION) 143 TABLE 74 INSULIN DELIVERY DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2024 (USD MILLION) 144 TABLE 75 INSULIN DELIVERY DEVICES MARKET FOR OTHER END USERS, BY REGION, 2025–2030 (USD MILLION) 145 TABLE 76 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2022–2024 (USD MILLION) 148 TABLE 77 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2025–2030 (USD MILLION) 148 TABLE 78 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 150 TABLE 79 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 150 TABLE 80 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 150 TABLE 81 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 151 TABLE 82 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 151 TABLE 83 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 151 TABLE 84 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 152 TABLE 85 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 152 TABLE 86 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 152 TABLE 87 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 153 TABLE 88 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 153 TABLE 89 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 153 TABLE 90 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 154 TABLE 91 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 154 TABLE 92 US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 155 TABLE 93 US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 155 TABLE 94 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 155 TABLE 95 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 156 TABLE 96 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 156 TABLE 97 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 156 TABLE 98 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 157 TABLE 99 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 157 TABLE 100 US: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 157 TABLE 101 US: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 158 TABLE 102 US: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 158 TABLE 103 US: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 158 TABLE 104 ELIGIBILITY FOR INSULIN PUMPS AND SUPPLIES IN CANADA FOR TYPE I DIABETES, 2023 159 TABLE 105 CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 161 TABLE 106 CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 161 TABLE 107 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 161 TABLE 108 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 162 TABLE 109 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 162 TABLE 110 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 162 TABLE 111 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 163 TABLE 112 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 163 TABLE 113 CANADA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 163 TABLE 114 CANADA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 164 TABLE 115 CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 164 TABLE 116 CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 164 TABLE 117 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 165 TABLE 118 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 166 TABLE 119 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 166 TABLE 120 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 167 TABLE 121 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 167 TABLE 122 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 167 TABLE 123 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 168 TABLE 124 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 168 TABLE 125 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 168 TABLE 126 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 169 TABLE 127 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 169 TABLE 128 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 169 TABLE 129 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 170 TABLE 130 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 170 TABLE 131 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 171 TABLE 132 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 171 TABLE 133 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 171 TABLE 134 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 172 TABLE 135 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 172 TABLE 136 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 172 TABLE 137 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 173 TABLE 138 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 173 TABLE 139 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 173 TABLE 140 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 174 TABLE 141 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 174 TABLE 142 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 174 TABLE 143 UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 175 TABLE 144 UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 175 TABLE 145 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 176 TABLE 146 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 176 TABLE 147 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 176 TABLE 148 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 177 TABLE 149 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 177 TABLE 150 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 177 TABLE 151 UK: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 178 TABLE 152 UK: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 178 TABLE 153 UK: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 178 TABLE 154 UK: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 179 TABLE 155 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 179 TABLE 156 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 180 TABLE 157 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 180 TABLE 158 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 180 TABLE 159 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 181 TABLE 160 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 181 TABLE 161 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 181 TABLE 162 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 182 TABLE 163 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 182 TABLE 164 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 182 TABLE 165 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 183 TABLE 166 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 183 TABLE 167 ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 184 TABLE 168 ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 184 TABLE 169 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 184 TABLE 170 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 185 TABLE 171 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 185 TABLE 172 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 185 TABLE 173 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 186 TABLE 174 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 186 TABLE 175 ITALY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 186 TABLE 176 ITALY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 187 TABLE 177 ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 187 TABLE 178 ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 187 TABLE 179 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 188 TABLE 180 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 188 TABLE 181 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 189 TABLE 182 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 189 TABLE 183 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 189 TABLE 184 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 190 TABLE 185 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 190 TABLE 186 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 190 TABLE 187 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 191 TABLE 188 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 191 TABLE 189 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 191 TABLE 190 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 192 TABLE 191 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 192 TABLE 192 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 193 TABLE 193 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 193 TABLE 194 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 193 TABLE 195 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 194 TABLE 196 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 194 TABLE 197 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 194 TABLE 198 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 195 TABLE 199 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 195 TABLE 200 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 195 TABLE 201 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 196 TABLE 202 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 196 TABLE 203 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 198 TABLE 204 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 198 TABLE 205 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 199 TABLE 206 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 199 TABLE 207 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 199 TABLE 208 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 200 TABLE 209 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 200 TABLE 210 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 200 TABLE 211 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 201 TABLE 212 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 201 TABLE 213 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 201 TABLE 214 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 202 TABLE 215 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 202 TABLE 216 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 202 TABLE 217 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 203 TABLE 218 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 204 TABLE 219 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 204 TABLE 220 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 204 TABLE 221 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 205 TABLE 222 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 205 TABLE 223 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 205 TABLE 224 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 206 TABLE 225 CHINA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 206 TABLE 226 CHINA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 206 TABLE 227 CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 207 TABLE 228 CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 207 TABLE 229 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 208 TABLE 230 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 208 TABLE 231 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 208 TABLE 232 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 209 TABLE 233 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 209 TABLE 234 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 209 TABLE 235 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 210 TABLE 236 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 210 TABLE 237 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 210 TABLE 238 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 211 TABLE 239 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 211 TABLE 240 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 211 TABLE 241 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 212 TABLE 242 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 213 TABLE 243 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 213 TABLE 244 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 213 TABLE 245 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 214 TABLE 246 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 214 TABLE 247 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 214 TABLE 248 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 215 TABLE 249 INDIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 215 TABLE 250 INDIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 215 TABLE 251 INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 216 TABLE 252 INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 216 TABLE 253 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 217 TABLE 254 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 217 TABLE 255 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 217 TABLE 256 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 218 TABLE 257 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 218 TABLE 258 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 218 TABLE 259 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 219 TABLE 260 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 219 TABLE 261 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 219 TABLE 262 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 220 TABLE 263 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 220 TABLE 264 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 220 TABLE 265 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 221 TABLE 266 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 221 TABLE 267 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 222 TABLE 268 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 222 TABLE 269 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 222 TABLE 270 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 223 TABLE 271 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 223 TABLE 272 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 223 TABLE 273 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 224 TABLE 274 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 224 TABLE 275 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 224 TABLE 276 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 225 TABLE 277 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 225 TABLE 278 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 226 TABLE 279 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 226 TABLE 280 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 226 TABLE 281 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 227 TABLE 282 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 227 TABLE 283 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 227 TABLE 284 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 228 TABLE 285 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 228 TABLE 286 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 228 TABLE 287 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 229 TABLE 288 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 229 TABLE 289 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 230 TABLE 290 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 230 TABLE 291 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 230 TABLE 292 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 231 TABLE 293 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 231 TABLE 294 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 231 TABLE 295 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 232 TABLE 296 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 232 TABLE 297 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 232 TABLE 298 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 233 TABLE 299 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 233 TABLE 300 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 233 TABLE 301 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 234 TABLE 302 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 234 TABLE 303 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 235 TABLE 304 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 235 TABLE 305 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 235 TABLE 306 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 236 TABLE 307 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 236 TABLE 308 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 236 TABLE 309 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 237 TABLE 310 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 237 TABLE 311 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 237 TABLE 312 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 238 TABLE 313 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 238 TABLE 314 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 238 TABLE 315 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 239 TABLE 316 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 239 TABLE 317 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 240 TABLE 318 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 240 TABLE 319 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 240 TABLE 320 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 241 TABLE 321 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 241 TABLE 322 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 241 TABLE 323 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 242 TABLE 324 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 242 TABLE 325 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 242 TABLE 326 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 243 TABLE 327 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 243 TABLE 328 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 244 TABLE 329 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 244 TABLE 330 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 244 TABLE 331 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 245 TABLE 332 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 245 TABLE 333 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 245 TABLE 334 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 246 TABLE 335 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 246 TABLE 336 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 246 TABLE 337 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 247 TABLE 338 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 247 TABLE 339 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 248 TABLE 340 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 248 TABLE 341 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 248 TABLE 342 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 249 TABLE 343 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 249 TABLE 344 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 249 TABLE 345 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 250 TABLE 346 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 250 TABLE 347 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 250 TABLE 348 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 251 TABLE 349 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 251 TABLE 350 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 251 TABLE 351 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 252 TABLE 352 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 252 TABLE 353 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 253 TABLE 354 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 253 TABLE 355 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 253 TABLE 356 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 254 TABLE 357 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 254 TABLE 358 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 254 TABLE 359 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 255 TABLE 360 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 255 TABLE 361 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 255 TABLE 362 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 256 TABLE 363 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 256 TABLE 364 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 256 TABLE 365 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 257 TABLE 366 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 257 TABLE 367 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 258 TABLE 368 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 258 TABLE 369 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 258 TABLE 370 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 259 TABLE 371 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 259 TABLE 372 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 259 TABLE 373 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 260 TABLE 374 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 260 TABLE 375 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 260 TABLE 376 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 261 TABLE 377 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN INSULIN DELIVERY DEVICES MARKET 262 TABLE 378 INSULIN DELIVERY DEVICE MARKET: DEGREE OF COMPETITION 265 TABLE 379 INSULIN DELIVERY DEVICES MARKET: TYPE FOOTPRINT, 2024 270 TABLE 380 INSULIN DELIVERY DEVICES MARKET: REGION FOOTPRINT, 2024 271 TABLE 381 INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024 274 TABLE 382 INSULIN DELIVERY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 275 TABLE 383 INSULIN DELIVERY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 278 TABLE 384 INSULIN DELIVERY DEVICES MARKET: DEALS, JANUARY 2022–APRIL 2025 285 TABLE 385 INSULIN DELIVERY DEVICES MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025 291 TABLE 386 INSULIN DELIVERY DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 294 TABLE 387 EMBECTA CORP.: BUSINESS OVERVIEW 296 TABLE 388 EMBECTA CORP.: PRODUCTS OFFERED 297 TABLE 389 EMBECTA CORP: PRODUCTS LAUNCHES & APPROVALS 298 TABLE 390 EMBECTA CORP: DEALS 298 TABLE 391 EMBECTA CORP: EXPANSIONS 299 TABLE 392 EMBECTA CORP.: OTHER DEVELOPMENTS 299 TABLE 393 NOVO NORDISK A/S: BUSINESS OVERVIEW 301 TABLE 394 NOVO NORDISK A/S: PRODUCTS OFFERED 302 TABLE 395 NOVO NORDISK A/S: PRODUCTS LAUNCHES & APPROVALS 303 TABLE 396 NOVO NORDISK A/S: DEALS 303 TABLE 397 NOVO NORDISK A/S: OTHER DEVELOPMENTS 305 TABLE 398 MEDTRONIC: BUSINESS OVERVIEW 307 TABLE 399 MEDTRONIC: PRODUCTS OFFERED 308 TABLE 400 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS 309 TABLE 401 MEDTRONIC: DEALS 310 TABLE 402 MEDTRONIC: EXPANSIONS 311 TABLE 403 MEDTRONIC: OTHER DEVELOPMENTS 311 TABLE 404 SANOFI: BUSINESS OVERVIEW 313 TABLE 405 SANOFI: PRODUCTS OFFERED 314 TABLE 406 SANOFI: PRODUCT LAUNCHES & APPROVALS 315 TABLE 407 SANOFI: EXPANSIONS 315 TABLE 408 SANOFI: OTHER DEVELOPMENTS 316 TABLE 409 ELI LILLY AND COMPANY: BUSINESS OVERVIEW 318 TABLE 410 ELI LILLY AND COMPANY: PRODUCTS OFFERED 319 TABLE 411 ELI LILLY AND COMPANY: PRODUCTS LAUNCHES 320 TABLE 412 ELI LILLY AND COMPANY: DEALS 320 TABLE 413 ELI LILLY AND COMPANY: EXPANSIONS 321 TABLE 414 ELI LILLY AND COMPANY: OTHER DEVELOPMENTS 321 TABLE 415 TANDEM DIABETES CARE, INC.: BUSINESS OVERVIEW 323 TABLE 416 TANDEM DIABETES CARE, INC.: PRODUCTS OFFERED 324 TABLE 417 TANDEM DIABETES CARE, INC.: PRODUCTS LAUNCHES & APPROVALS 325 TABLE 418 TANDEM DIABETES CARE, INC.: DEALS 326 TABLE 419 INSULET CORPORATION: BUSINESS OVERVIEW 328 TABLE 420 INSULET CORPORATION: PRODUCTS LAUNCHES & APPROVALS 330 TABLE 421 INSULET CORPORATION: DEALS 332 TABLE 422 INSULET CORPORATION: EXPANSIONS 332 TABLE 423 INSULET CORPORATION: OTHER DEVELOPMENTS 333 TABLE 424 BIOCON: BUSINESS OVERVIEW 334 TABLE 425 BIOCON: PRODUCTS OFFERED 335 TABLE 426 BIOCON: DEALS 336 TABLE 427 BIOCON: OTHER DEVELOPMENTS 337 TABLE 428 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 338 TABLE 429 F. HOFFMANN-LA ROCHE: PRODUCTS OFFERED 339 TABLE 430 HOFFMANN-LA ROCHE LTD.: PRODUCTS LAUNCHES 340 TABLE 431 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): BUSINESS OVERVIEW 341 TABLE 432 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): PRODUCTS OFFERED 342 TABLE 433 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): DEALS 342 TABLE 434 YPSOMED: BUSINESS OVERVIEW 343 TABLE 435 YPSOMED: PRODUCTS OFFERED 344 TABLE 436 YPSOMED: PRODUCT LAUNCHES & APPROVALS 345 TABLE 437 YPSOMED: DEALS 346 TABLE 438 YPSOMED: EXPANSIONS 347 TABLE 439 YPSOMED: OTHER DEVELOPMENTS 348 TABLE 440 MEDTRUM TECHNOLOGIES INC.: BUSINESS OVERVIEW 349 TABLE 441 MEDTRUM TECHNOLOGIES INC.: PRODUCT PORTFOLIO 349 TABLE 442 TERUMO CORPORATION: BUSINESS OVERVIEW 350 TABLE 443 TERUMO CORPORATION: PRODUCTS OFFERED 351 TABLE 444 TERUMO CORPORATION: PRODUCT LAUNCHES 352 TABLE 445 TERUMO CORPORATION: DEALS 352 TABLE 446 TERUMO CORPORATION: EXPANSIONS 353 TABLE 447 TERUMO CORPORATION: OTHER DEVELOPMENTS 353 TABLE 448 WOCKHARDT LIMITED: BUSINESS OVERVIEW 354 TABLE 449 WOCKHARDT LIMITED: PRODUCTS OFFERED 355 TABLE 450 WOCKHARDT LIMITED: PRODUCTS LAUNCHES 355 TABLE 451 WOCKHARDT LIMITED: OTHER DEVELOPMENTS 356 TABLE 452 NIPRO: BUSINESS OVERVIEW 357 TABLE 453 NIPRO: PRODUCTS OFFERED 358 TABLE 454 NIPRO: EXPANSIONS 359 FIGURE 1 INSULIN DELIVERY DEVICES MARKET SEGMENTATION 35 FIGURE 2 STUDY YEARS CONSIDERED 36 FIGURE 3 RESEARCH DESIGN 39 FIGURE 4 KEY DATA FROM SECONDARY SOURCES 41 FIGURE 5 PRIMARY SOURCES 42 FIGURE 6 KEY DATA FROM PRIMARY SOURCES 43 FIGURE 7 KEY INDUSTRY INSIGHTS 43 FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 44 FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 44 FIGURE 10 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 45 FIGURE 11 TOP-DOWN APPROACH 46 FIGURE 12 INSULIN DELIVERY DEVICES MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 47 FIGURE 13 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 48 FIGURE 14 DATA TRIANGULATION METHODOLOGY 49 FIGURE 15 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 52 FIGURE 16 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025 VS. 2030 (USD MILLION) 53 FIGURE 17 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 53 FIGURE 18 GEOGRAPHICAL SNAPSHOT OF INSULIN DELIVERY DEVICES MARKET 54 FIGURE 19 INCREASING TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY DEVICES TO DRIVE MARKET 56 FIGURE 20 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE OF INSULIN DELIVERY DEVICES MARKET IN 2024 57 FIGURE 21 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 58 FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2025–2030) 58 FIGURE 23 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 59 FIGURE 24 INSULIN DELIVERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60 FIGURE 25 ESTIMATES OF GLOBAL PREVALENCE OF DIABETES IN 20–79-YEAR AGE GROUP, 2011–2024 (MILLION) 61 FIGURE 26 DIABETES AGE-STANDARDIZED PREVALENCE IN PEOPLE (65–99 YEARS), BY REGION, 2024 AND 2050 (MILLION) 62 FIGURE 27 ADVANCEMENTS IN INSULIN DELIVERY DEVICES 63 FIGURE 28 FDA 510(K) APPROVAL PROCESS 73 FIGURE 29 EUROPE: CE MARK APPROVAL PROCESS FOR INSULIN DELIVERY DEVICES 75 FIGURE 30 SUMMARY OF APPROVAL, ACCESS, AND DISTRIBUTION PATHWAYS FOR NEW TECHNOLOGY USED FOR INSULIN DRUG DELIVERY DEVICES 78 FIGURE 31 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR INSULIN DELIVERY DEVICES MARKET, JANUARY 2014–DECEMBER 2024 91 FIGURE 32 TOP PATENT APPLICANT COUNTRIES FOR INSULIN DELIVERY DEVICES, JANUARY 2014–DECEMBER 2024 92 FIGURE 33 INSULIN DELIVERY DEVICE MARKET: SUPPLY CHAIN ANALYSIS 94 FIGURE 34 INSULIN DELIVERY DEVICE: VALUE CHAIN ANALYSIS 95 FIGURE 35 INSULIN DELIVERY DEVICE MARKET: ECOSYSTEM MAPPING 96 FIGURE 36 INSULIN DELIVERY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 98 FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS 100 FIGURE 38 KEY BUYING CRITERIA FOR END USERS 101 FIGURE 39 INSULIN DELIVERY DEVICES MARKET: ADJACENT MARKET ANALYSIS 102 FIGURE 40 INVESTMENT/VENTURE CAPITAL SCENARIO IN INSULIN DELIVERY DEVICES, 2021–2023 (USD MILLION) 102 FIGURE 41 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHIC SNAPSHOT 147 FIGURE 42 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SNAPSHOT 149 FIGURE 43 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET SNAPSHOT 197 FIGURE 44 REVENUE SHARE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 264 FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 265 FIGURE 46 INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 268 FIGURE 47 INSULIN DELIVERY DEVICES MARKET: COMPANY FOOTPRINT, 2024 269 FIGURE 48 INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 273 FIGURE 49 INSULIN DELIVERY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 276 FIGURE 50 EV/EBITDA OF KEY VENDORS, 2024 277 FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024 277 FIGURE 52 R&D ASSESSMENT OF KEY PLAYERS 278 FIGURE 53 EMBECTA CORP.: COMPANY SNAPSHOT, 2024 297 FIGURE 54 NOVO NORDISK A/S: COMPANY SNAPSHOT, 2024 302 FIGURE 55 MEDTRONIC: COMPANY SNAPSHOT, 2024 308 FIGURE 56 SANOFI: COMPANY SNAPSHOT, 2024 314 FIGURE 57 ELI LILLY AND COMPANY: COMPANY SNAPSHOT, 2024 319 FIGURE 58 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT, 2024 324 FIGURE 59 INSULET CORPORATION: COMPANY SNAPSHOT, 2024 329 FIGURE 60 BIOCON: COMPANY SNAPSHOT, 2024 335 FIGURE 61 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT, 2024 339 FIGURE 62 YPSOMED: COMPANY SNAPSHOT, 2024 344 FIGURE 63 TERUMO CORPORATION: COMPANY SNAPSHOT, 2024 351 FIGURE 64 WOCKHARDT LIMITED: COMPANY SNAPSHOT, 2024 355 FIGURE 65 NIPRO: COMPANY SNAPSHOT, 2024 358

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（醫療器材）